Owner Novartis AG

Inventors Bianchi, Jean-Claude; Kalb, Oskar; Luftensteiner, Christian-Peter; Ogorka, Jorg

Agent Davies Collison Cave

Pub. Number AU-A-2010200509

Parent 2007201830

Filing date 11 February 2010

Wipo publication date 4 March 2010

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents